Skip to main content
. 2022 Mar 14;66(4):e02108-21. doi: 10.1128/aac.02108-21

FIG 2.

FIG 2

Mean plasma concentration-time profiles of PNU-101603 after single doses of 300-mg (cohort 1), 600-mg (cohort 2), 1,200-mg (cohort 3), and 1,800-mg (cohort 4) sutezolid tablets on linear and semilogarithmic scales (top and bottom panels, respectively).